Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.40p
   
  • Change Today:
    -0.050p
  • 52 Week High: 5.34
  • 52 Week Low: 1.60
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 336,570
  • Market Cap: £25.00m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Director Shareholdings

Notifier Holding Value*
Hans-Peter Hasler 5,500,000 £132,000
Anders Lundstrom 575,000 £13,800

Major Shareholders

Notifier** Holding Value*
AOP Orphan Pharmaceuticals AG 158,070,394 £3,793,690
Nutrition-Wellness Venture SA 56,008,541 £1,344,205
Jupiter Fund Management plc 34,127,697 £819,065
MaRu AG 12,532,918 £300,790
JPMorgan Asset Management Holdings Inc. 6,238,846 £149,732
Universities Superannuation Scheme Ltd 5,067,985 £121,632
Spreadex Ltd 4,123,006 £98,952

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.40p
Change Today -0.050p
% Change -2.04 %
52 Week High 5.34
52 Week Low 1.60
Volume 336,570
Shares Issued 1,041.69m
Market Cap £25.00m
Beta 0.00

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.36% below the market average12.36% below the market average12.36% below the market average12.36% below the market average12.36% below the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Price Trend
33% below the market average33% below the market average33% below the market average33% below the market average33% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Income Not Available
Growth
62.67% above the market average62.67% above the market average62.67% above the market average62.67% above the market average62.67% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
16:19 10,000 @ 2.42p
16:12 80,000 @ 2.33p
15:57 42,016 @ 2.38p
15:41 5,676 @ 2.33p
14:41 6,600 @ 2.44p

STX Key Personnel

CEO Anders Lundstrom

Top of Page